Try our Advanced Search for more refined results
November 17, 2022
Leslie Lilien v. Olaplex Holdings, Inc. et al
Case Number:
2:22-cv-08395
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Bleichmar Fonti
- Glancy Prongay
- Kahn Swick
- Labaton Keller
- Levi & Korsinsky
- Morgan Lewis
- Pomerantz LLP
- Ropes & Gray
- Rosen Law Firm PA
- Willkie Farr
Companies
- Advent International Corp.
- Barclays PLC
- Drexel Hamilton LLC
- Evercore Inc.
- Jefferies Financial Group Inc.
- JPMorgan Chase & Co.
- Loop Capital Markets LLC
- Morgan Stanley
- Piper Sandler Cos.
- Raymond James Financial Inc.
- The Goldman Sachs Group Inc.
Government Agencies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
February 11, 2025
Olaplex Can't Escape IPO Investors' Formula Change Suit
Olaplex and some of its executives must face investor claims that the company's initial public offering documents did not disclose the European Union had banned a controversial ingredient known as lilial, which would impact Olaplex's main product offering, but the IPO underwriters and selling stockholders were allowed to escape the suit.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login